Literature DB >> 4018737

Localization of increased hepatic vascular resistance in liver cirrhosis.

Y Shibayama, K Nakata.   

Abstract

To determine the localization of increased vascular resistance in cirrhotic liver, blood pressures were measured by a direct cannulation method at several key points in the hepatic vascular pathway in normal and cirrhotic rats. Cirrhosis was produced by feeding a choline-deficient diet. Blood pressures in normal rats were 110 mm H2O in the portal vein, 68 mm H2O in the terminal portal venule, 28 mm H2O in the terminal hepatic venule and 20 mm H2O in the inferior vena cava. In cirrhotic rats, blood pressures in the portal vein and the terminal portal venule were 173 and 100 mm H2O, respectively, while those in the terminal hepatic venule and the inferior vena cava were elevated only slightly above normal. These hemodynamic data suggest that an increase in vascular resistance in cirrhotic liver is present in the intrahepatic portal vein and sinusoids, but not in intrahepatic hepatic vein. In cirrhotic liver, stenosis and distortion were found in peripheral branches of the portal vein, and sinusoidal stenoses and a decrease in sinusoidal space were recognized. Accordingly, it is suggested that the increase in vascular resistance in the intrahepatic portal vein and sinusoids correlate with these structural changes. Although severe stenoses and distortion were found in hepatic vein branches, it was thought that they do not contribute to portal hypertension because of lack of increase in vascular resistance in the intrahepatic hepatic vein.

Entities:  

Mesh:

Year:  1985        PMID: 4018737     DOI: 10.1002/hep.1840050421

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

Review 1.  Current management of the complications of portal hypertension: variceal bleeding and ascites.

Authors:  Nina Dib; Frédéric Oberti; Paul Calès
Journal:  CMAJ       Date:  2006-05-09       Impact factor: 8.262

2.  A new rat model of portal hypertension induced by intraportal injection of microspheres.

Authors:  Xiang-Nong Li; IS Benjamin; B Alexander
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

3.  Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids.

Authors:  V Shah; F G Haddad; G Garcia-Cardena; J A Frangos; A Mennone; R J Groszmann; W C Sessa
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

4.  Plasma endothelin-1 concentrations are elevated in acute hepatitis and liver cirrhosis but not in chronic hepatitis.

Authors:  Y Uchida; M Watanabe
Journal:  Gastroenterol Jpn       Date:  1993-10

5.  Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1.

Authors:  C Housset; D C Rockey; D M Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

6.  Increased sinusoidal resistance is responsible for the basal state and endothelin-induced venoconstriction in perfused cirrhotic rat liver.

Authors:  Toshishige Shibamoto; Chiaki Kamikado; Shozo Koyama
Journal:  Pflugers Arch       Date:  2008-01-05       Impact factor: 3.657

7.  Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis.

Authors:  S K Sarin; K K Sethi; R Nanda
Journal:  Gut       Date:  1987-03       Impact factor: 23.059

8.  Quantitative modeling of the physiology of ascites in portal hypertension.

Authors:  David G Levitt; Michael D Levitt
Journal:  BMC Gastroenterol       Date:  2012-03-27       Impact factor: 3.067

9.  Modeling of xenobiotic transport and metabolism in virtual hepatic lobule models.

Authors:  Xiao Fu; James P Sluka; Sherry G Clendenon; Kenneth W Dunn; Zemin Wang; James E Klaunig; James A Glazier
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

Review 10.  Hepatic circulation: potential for therapeutic intervention.

Authors:  F Ballet
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.